Concentric remodeling and the metabolic-associated steatotic liver disease in patients with type 1 diabetes: an

Klaudia Czarnik1, Zbigniew Sablik2, Anna Borkowska3

  • 1Department of Internal Diseases and Diabetology, Medical University of Lodz, Central Teaching Hospital in Lodz, 251 Pomorska Street, 92-213, Lodz, Poland. klaudia.czarnik@umed.lodz.pl.

Acta Diabetologica
|September 17, 2024
PubMed

Insights

In young patients with type 1 diabetes (T1D), a higher Fatty Liver Index (FLI) correlates with increased risk of left ventricle (LV) remodeling. This suggests FLI may help identify T1D patients needing closer cardiac monitoring.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetic cardiomyopathy in type 1 diabetes (T1D) often presents as asymptomatic diastolic dysfunction and left ventricle (LV) remodeling.
  • The role of metabolic-associated steatotic liver disease (MASLD) in T1D-related cardiac remodeling is understudied.
  • This research investigates the link between MASLD risk and LV remodeling in young T1D patients without heart failure.

Purpose of the Study:

  • To determine the correlation between MASLD risk, assessed by Fatty Liver Index (FLI), and relative wall thickness (RWT) in young T1D patients.
  • To explore the association between FLI and LV remodeling indicators in T1D.
  • To identify potential predictors of cardiac remodeling in T1D.

Main Methods:

  • Recruitment of T1D patients from an inpatient diabetology department.
  • Collection of laboratory test results and echocardiographic data.
  • Estimation of MASLD risk using FLI and statistical analysis of acquired data.

Main Results:

  • The study included 55 T1D patients; 25 exhibited LV remodeling (RWT > 0.42).
  • Patients with LV remodeling had significantly higher FLI (40.97 vs. 13.82) and BMI (27.3 vs. 22.5).
  • FLI demonstrated a correlation with LV remodeling risk (OR 1.028, p=0.05), with an optimal predictive FLI cutoff of 26.38 for RWT > 0.42.

Conclusions:

  • Fatty Liver Index (FLI) is correlated with relative wall thickness (RWT) in T1D patients.
  • This association is independent of diabetes metabolic control.
  • FLI may serve as a valuable tool for identifying T1D patients at higher risk for left ventricle remodeling.
Abstract

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.7K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
76
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K